Rossari Biotech Limited — Board Meeting, 18-07-2026: Outcome of Board Meeting

Rossari Biotech's board on July 18, 2026, approved Q1 consolidated results: Revenue Rs 697.2 Cr, PAT Rs 35.1 Cr, EPS Rs 6.34. Also approved 4,000 ESOP grants, allotted 2,500 shares, and a Rs 24 Cr internal transfer of its Saudi subsidiary for streamlined overseas reporting.